Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2024Open Access

A model based on Immunogenic cell death-related genes can predict prognosis and drug sensitivity in patients with hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJianfei ShiHebei Medical UniversityHZHua ZhangChinese Research Academy of Environmental SciencesXHXin HanHebei Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shi et al. (2024) studied this question.

synapsesocial.com/papers/68e79176b6db6435877028a8https://doi.org/10.21203/rs.3.rs-3940391/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic roles of MAGE family�members in breast cancer based on KM‑Plotter Data2019 · 38 citations
  2. 2Hepatocellular Carcinoma2019 · 4,761 citations
  3. 3Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression2023 · 19 citations
  4. 4MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama2023 · 2 citations
  5. 5oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data2021 · 1,862 citations